文献速递传染病防控与疫情报告免疫规划

针对性预防性疫苗接种活动以减少埃博拉疫情:基于个体的建模研究

Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study.
PubMed 文献 · Vaccine · 2022-12-14

本研究采用空间显式个体模型模拟刚果民主共和国的埃博拉传播,评估在非药物干预和环状疫苗接种基础上增加预防性疫苗接种的效果。结果显示,预防性接种医护人员、一线人员及普通人群可不同程度减少病例、住院和死亡,尤其在疫情初期作用明显,使流行曲线更平缓。

要点

  • 在NPI+环状接种基础上增加医护人员预防性接种,病例、住院和死亡减少约11%至25%。
  • 纳入医护人员和一线人员接种可带来约14%至38%的疫情结局改善。
  • 进一步纳入普通人群接种改善最大,疫情结局减少约21%至52%。

核心结论

  • 个体模型显示预防性疫苗接种可能减少埃博拉病例、住院和死亡,从而保护医疗系统并为实施其他干预措施争取时间。

研究设计与样本

  • 构建空间显式、基于个体的模型(IBM),考虑人类接触异质性、人群移动和干预时机,以代表刚果民主共和国的埃博拉传播。
  • 模拟的预防性疫苗接种策略针对医护人员(HCW)、一线人员(FW)和普通人群(GP),覆盖率设较低水平(HCW/FW 30%,GP 5%)和较高水平(HCW/FW 60%,GP 10%),疫苗效力设较低(60%)和较高(90%)两档。

主要发现

  • 与仅用NPI+环状接种相比,增加医护人员预防性接种使病例、住院和死亡减少约11%至25%。
  • 将医护人员和一线人员纳入预防性接种活动,疫情结局改善约14%至38%。
  • 进一步纳入普通人群改善最大,与仅用NPI+环状接种相比疫情结局减少约21%至52%。
  • 在无环状接种的情景下,与仅用NPI相比,预防性接种使病例、住院和死亡减少约28%至59%。
  • 在所有情景中,预防性接种均在疫情初期尤其减少埃博拉传播,使流行曲线更平缓。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Nonpharmaceutical interventions (NPI) and ring vaccination (i.e., vaccination that primarily targets contacts and contacts of contacts of Ebola cases) are currently used to reduce the spread of Ebola during outbreaks. Because these measures are typically initiated after an outbreak is declared, they are limited by real-time implementation challenges. Preventive vaccination may provide a complementary option to help protect communities against unpredictable outbreaks. This study aimed to assess the impact of preventive vaccination strategies when implemented in conjunction with NPI and ring vaccination. METHODS: A spatial-explicit, individual-based model (IBM) that accounts for heterogeneity of human contact, human movement, and timing of interventions was built to represent Ebola transmission in the Democratic Republic of the Congo. Simulated preventive vaccination strategies targeted healthcare workers (HCW), frontline workers (FW), and the general population (GP) with varying levels of coverage (lower coverage: 30% of HCW/FW, 5% of GP; higher coverage: 60% of HCW/FW, 10% of GP) and efficacy (lower efficacy: 60%; higher efficacy: 90%). RESULTS: The IBM estimated that the addition of preventive vaccination for HCW reduced cases, hospitalizations, and deaths by ∼11 % to ∼25 % compared with NPI + ring vaccination alone. Including HCW and FW in the preventive vaccination campaign yielded ∼14 % to ∼38 % improvements in epidemic outcomes. Further including the GP yielded the greatest improvements, with ∼21 % to ∼52 % reductions in epidemic outcomes compared with NPI + ring vaccination alone. In a scenario without ring vaccination, preventive vaccination reduced cases, hospitalizations, and deaths by ∼28 % to ∼59 % compared with NPI alone. In all scenarios, preventive vaccination reduced Ebola transmission particularly during the initial phases of the epidemic, resulting in flatter epidemic curves. CONCLUSIONS: The IBM showed that preventive vaccination may reduce Ebola cases, hospitalizations, and deaths, thus safeguarding the healthcare system and providing more time to implement additional interventions during an outbreak.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bisanzio D, Davis AE, Talbird SE, et al. Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study. Vaccine. 2022. PMID: 36526505. doi:10.1016/j.vaccine.2022.11.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。